• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于坏死性小肠结肠炎早期诊断的新型评分系统:将临床和实验室数据与尿中窖蛋白-1水平相结合

Novel scoring system for early diagnosis of necrotizing enterocolitis: integrating clinical and laboratory data with urinary caveolin-1 levels.

作者信息

Corebima Brigitta I R V, Rohsiswatmo Rinawati, Santosaningsih Dewi, Barlianto Wisnu, Handono Kusworini

机构信息

Doctoral Program in Medical Science, Faculty of Medicine, Brawijaya University, Indonesia.

Department of Pediatrics, Faculty of Medicine, Brawijaya University/Saiful Anwar General Hospital, Indonesia.

出版信息

Arch Med Sci. 2023 Nov 16;20(2):444-456. doi: 10.5114/aoms/173390. eCollection 2024.

DOI:10.5114/aoms/173390
PMID:38757010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11094821/
Abstract

INTRODUCTION

Necrotizing enterocolitis (NEC) poses a significant threat to preterm infants, with nonspecific early manifestations complicating timely diagnosis. Therefore, this study aimed to develop a novel scoring system for early diagnosis of NEC, incorporating clinical and laboratory data with urinary caveolin-1 levels.

MATERIAL AND METHODS

A single-center prospective cohort study was conducted at a tertiary hospital in East Java, Indonesia. NEC diagnosis was established by Bell's criteria and proven gut dysbiosis. Urinary levels of claudin-2, caveolin-1, and epidermal growth factor (EGF) were assessed as potential indicators of tight junction disruption. The selected urine biomarker cutoff value was determined using symbolic classification analysis and combined with clinical and laboratory parameters from Bell's criteria to create an NEC scoring system, validated with the Aiken index. Sensitivity and specificity analyses were performed.

RESULTS

Thirty-four neonates, comprising NEC, preterm non-NEC, and term infants, were included. qPCR analysis highlighted elevated , , , and levels in NEC patients, indicating a gut dysbiosis trend. Among 3 biomarkers, caveolin-1 ≥ 17.81 ng/dl on day 3 demonstrated 72.86% negative predictive value and 87.50% positive predictive value. The combined scoring system which comprised abdominal cellulitis, distension, radiology, advanced resuscitation at birth, prematurity or low birthweight, platelet count, sepsis, orogastric retention, metabolic acidosis and caveolin-1 findings exhibited an AUC of 0.922 (95% CI: 0.81-1.00, < 0.001), with ≥ 1.81 as the cutoff, offering 93% sensitivity and 94% specificity.

CONCLUSIONS

Urine caveolin-1 on day 3 signifies enterocyte tight junction damage and the acute phase of NEC in premature infants. The proposed scoring system demonstrates good performance in predicting NEC incidence in preterm infants.

摘要

引言

坏死性小肠结肠炎(NEC)对早产儿构成重大威胁,其早期表现不具特异性,这使得及时诊断变得复杂。因此,本研究旨在开发一种用于NEC早期诊断的新型评分系统,将临床和实验室数据与尿中窖蛋白-1水平相结合。

材料与方法

在印度尼西亚东爪哇的一家三级医院进行了一项单中心前瞻性队列研究。NEC诊断依据贝尔标准并经肠道菌群失调证实。评估了紧密连接破坏的潜在指标,即尿中闭合蛋白-2、窖蛋白-1和表皮生长因子(EGF)的水平。使用符号分类分析确定所选尿生物标志物的临界值,并将其与贝尔标准中的临床和实验室参数相结合,创建了一个NEC评分系统,并用艾肯指数进行验证。进行了敏感性和特异性分析。

结果

纳入了34例新生儿,包括NEC患儿、早产非NEC患儿和足月儿。定量聚合酶链反应分析突出显示NEC患者中[此处原文缺失具体基因名称]、[此处原文缺失具体基因名称]、[此处原文缺失具体基因名称]和[此处原文缺失具体基因名称]水平升高,表明存在肠道菌群失调趋势。在3种生物标志物中,第3天窖蛋白-1≥17.81 ng/dl时,阴性预测值为72.86%,阳性预测值为87.50%。由腹部蜂窝织炎、腹胀、放射学检查、出生时高级复苏、早产或低出生体重、血小板计数、败血症、胃潴留、代谢性酸中毒和窖蛋白-1检查结果组成的联合评分系统的曲线下面积为0.922(95%置信区间:0.81 - 1.00,P<0.001),临界值≥1.81,敏感性为93%,特异性为94%。

结论

第3天的尿窖蛋白-1表明早产儿肠上皮细胞紧密连接受损及NEC急性期。所提出的评分系统在预测早产儿NEC发生率方面表现良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/e5c05e0abf49/AMS-20-2-173390-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/20e5ce7497c5/AMS-20-2-173390-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/0df07eb5200f/AMS-20-2-173390-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/6936a7b907f6/AMS-20-2-173390-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/1d1da1532094/AMS-20-2-173390-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/e5c05e0abf49/AMS-20-2-173390-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/20e5ce7497c5/AMS-20-2-173390-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/0df07eb5200f/AMS-20-2-173390-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/6936a7b907f6/AMS-20-2-173390-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/1d1da1532094/AMS-20-2-173390-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f07/11094821/e5c05e0abf49/AMS-20-2-173390-g005.jpg

相似文献

1
Novel scoring system for early diagnosis of necrotizing enterocolitis: integrating clinical and laboratory data with urinary caveolin-1 levels.用于坏死性小肠结肠炎早期诊断的新型评分系统:将临床和实验室数据与尿中窖蛋白-1水平相结合
Arch Med Sci. 2023 Nov 16;20(2):444-456. doi: 10.5114/aoms/173390. eCollection 2024.
2
Risk factors of necrotising enterocolitis among 28-34 weeks preterm neonates at a Tertiary Care Hospital, East Java, Indonesia.印度尼西亚东爪哇省一家三级保健医院 28-34 周早产儿坏死性小肠结肠炎的危险因素。
Med J Malaysia. 2023 Jul;78(4):458-465.
3
Unraveling the Microbiome of Necrotizing Enterocolitis: Insights in Novel Microbial and Metabolomic Biomarkers.解析坏死性小肠结肠炎的微生物组学:新型微生物和代谢组学生物标志物的研究进展。
Microbiol Spectr. 2021 Oct 31;9(2):e0117621. doi: 10.1128/Spectrum.01176-21. Epub 2021 Oct 27.
4
Early diagnosis of necrotizing enterocolitis by plasma RELMβ and thrombocytopenia in preterm infants: A pilot study.早产儿血浆 RELMβ 和血小板减少症早期诊断坏死性小肠结肠炎:一项初步研究。
Pediatr Neonatol. 2019 Aug;60(4):447-452. doi: 10.1016/j.pedneo.2019.01.006. Epub 2019 Jan 22.
5
Routine fecal occult blood testing does not predict necrotizing enterocolitis in very low birth weight neonates.常规粪便潜血检测无法预测极低出生体重新生儿的坏死性小肠结肠炎。
J Neonatal Perinatal Med. 2016 May 19;9(2):171-8. doi: 10.3233/NPM-16915120.
6
The β-glucosidase assay: a new diagnostic tool for necrotizing enterocolitis. Sensitivity, specificity, and predictive values.β-葡萄糖苷酶检测:一种用于坏死性小肠结肠炎的新诊断工具。敏感性、特异性及预测值。
Eur J Pediatr. 2016 Jul;175(7):931-41. doi: 10.1007/s00431-016-2724-8. Epub 2016 Apr 27.
7
Necrotizing enterocolitis - classification and two initial steps towards prevention.坏死性小肠结肠炎——分类及预防的两个初步措施
Dan Med J. 2017 Jun;64(6).
8
The Metabolome and the Gut Microbiota for the Prediction of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation: A Systematic Review.代谢组学和肠道微生物组预测坏死性小肠结肠炎和自发性肠穿孔:系统评价。
Nutrients. 2022 Sep 18;14(18):3859. doi: 10.3390/nu14183859.
9
Risk factors for necrotizing enterocolitis and establishment of prediction model of necrotizing enterocolitis in preterm infants.坏死性小肠结肠炎的危险因素及早产儿坏死性小肠结肠炎预测模型的建立。
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Jan 15;24(1):41-48. doi: 10.7499/j.issn.1008-8830.2109086.
10
Predictive factors for the surgical treatment of necrotizing enterocolitis in preterm infants: a single-center retrospective study.预测指标在早产儿坏死性小肠结肠炎手术治疗中的作用:单中心回顾性研究。
BMC Pediatr. 2022 Jan 3;22(1):9. doi: 10.1186/s12887-021-02973-w.

本文引用的文献

1
Risk factors of necrotising enterocolitis among 28-34 weeks preterm neonates at a Tertiary Care Hospital, East Java, Indonesia.印度尼西亚东爪哇省一家三级保健医院 28-34 周早产儿坏死性小肠结肠炎的危险因素。
Med J Malaysia. 2023 Jul;78(4):458-465.
2
Early gut microbiota in very low and extremely low birth weight preterm infants with feeding intolerance: a prospective case-control study.极低和超低出生体重早产儿喂养不耐受的早期肠道微生物群:一项前瞻性病例对照研究。
J Microbiol. 2022 Oct;60(10):1021-1031. doi: 10.1007/s12275-022-2180-2. Epub 2022 Aug 19.
3
Dynamic Changes of the Gut Microbiota in Preterm Infants With Different Gestational Age.
不同孕周早产儿肠道微生物群的动态变化
Front Microbiol. 2022 Jun 30;13:923273. doi: 10.3389/fmicb.2022.923273. eCollection 2022.
4
miRNA-21 plays an important role in necrotizing enterocolitis.微小RNA-21在坏死性小肠结肠炎中起重要作用。
Arch Med Sci. 2019 Sep 17;18(2):406-412. doi: 10.5114/aoms.2019.88013. eCollection 2022.
5
Ethical dilemmas in the management of infants with necrotizing enterocolitis totalis.全肠坏死性小肠结肠炎患儿处理中的伦理困境
J Pediatr Surg. 2022 Mar;57(3):329-334. doi: 10.1016/j.jpedsurg.2021.08.026. Epub 2021 Sep 21.
6
Sample size determination and power analysis using the G*Power software.使用 G*Power 软件进行样本量确定和功效分析。
J Educ Eval Health Prof. 2021;18:17. doi: 10.3352/jeehp.2021.18.17. Epub 2021 Jul 30.
7
A critical evaluation of current definitions of necrotizing enterocolitis.对当前坏死性小肠结肠炎定义的批判性评估。
Pediatr Res. 2022 Feb;91(3):590-597. doi: 10.1038/s41390-021-01570-y. Epub 2021 May 21.
8
Review of claudin proteins as potential biomarkers for necrotizing enterocolitis.Claudin 蛋白作为坏死性小肠结肠炎潜在生物标志物的研究进展。
Ir J Med Sci. 2021 Nov;190(4):1465-1472. doi: 10.1007/s11845-020-02490-2. Epub 2021 Jan 25.
9
Emerging Biomarkers for Prediction and Early Diagnosis of Necrotizing Enterocolitis in the Era of Metabolomics and Proteomics.代谢组学和蛋白质组学时代坏死性小肠结肠炎预测与早期诊断的新兴生物标志物
Front Pediatr. 2020 Dec 8;8:602255. doi: 10.3389/fped.2020.602255. eCollection 2020.
10
Defining necrotizing enterocolitis: current difficulties and future opportunities.定义坏死性小肠结肠炎:当前的困难和未来的机遇。
Pediatr Res. 2020 Aug;88(Suppl 1):10-15. doi: 10.1038/s41390-020-1074-4.